Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update
Article content Successfully closed upsized IPO, raising $88 million in gross proceeds to continue advancing pipeline of Selected TIL Therapy...
Article content Successfully closed upsized IPO, raising $88 million in gross proceeds to continue advancing pipeline of Selected TIL Therapy...